Want to see IN:YATHARTH full AI Analyst Report?
YATHARTH Stock Chart & Stats
₹699.80
-₹11.35(-2.06%)
At close: 4:00 PM EST
₹699.80
-₹11.35(-2.06%)
Day’s Range― - ―
52-Week Range₹538.15 - ₹889.80
Previous CloseN/A
Volume440.50K
Average Volume (3M)28.98K
Market Cap
₹83.39B
Enterprise Value₹79.15B
Total Cash (Recent Filing)₹2.63B
Total Debt (Recent Filing)₹2.64B
Price to Earnings (P/E)47.2
Beta1.42
Next Earnings
Aug 19, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)18.28
Shares Outstanding96,354,355
10 Day Avg. Volume38,534
30 Day Avg. Volume28,985
Financial Highlights & Ratios
PEG Ratio1.43
Price to Book (P/B)3.34
Price to Sales (P/S)4.93
P/FCF Ratio-62.15
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)27.31
Revenue Forecast (FY)₹16.66B
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthSustained top-line expansion (~36% revenue growth) reflects rising patient volumes and successful scaling of the hospital network. Over the next 2–6 months this durable demand trajectory supports capacity utilization, incremental operating leverage, and long-term revenue visibility independent of short-term market moves.
Healthy Profitability MarginsReported EBITDA (~24%) and net margins (~14.5%) indicate the core hospital operations generate meaningful operating cash potential and pricing power across specialties. These margins provide a structural buffer to absorb cost fluctuations and fund reinvestment in facilities and talent over multiple quarters.
Materially Improved LeverageA sharp improvement in leverage to roughly 0.15x versus prior >2x levels materially strengthens financial resilience. Lower structural leverage reduces interest burden, improves access to credit markets, and provides headroom to fund targeted expansion or partnerships without immediate equity dilution.
Bears Say
Negative, Volatile Free Cash FlowDespite positive operating cash in the latest year, persistent negative free cash flow in FY2025–FY2026 and historical volatility reduce durable financial flexibility. Continued negative FCF forces reliance on external funding for capex and expansion, raising refinancing and execution risk over the medium term.
Margin Compression Versus Prior YearsReported compression of gross/EBIT/EBITDA margins versus earlier years signals rising cost pressures or an adverse case-mix as the business scales. If sustained, this structural margin squeeze can erode earnings quality and limit the firm's ability to convert revenue growth into durable free cash flow.
Recent Step-up In Total DebtA pronounced increase in total debt in the latest year introduces renewed leverage risk despite long-run improvement. Coupled with negative FCF and margin pressure, higher debt raises interest and refinancing exposure and may constrain strategic flexibility if cash generation does not firm sustainably.
Yatharth Hospital and Trauma Care Services Limited News
YATHARTH FAQ
What was Yatharth Hospital and Trauma Care Services Limited’s price range in the past 12 months?
Yatharth Hospital and Trauma Care Services Limited lowest stock price was ₹538.15 and its highest was ₹889.80 in the past 12 months.
What is Yatharth Hospital and Trauma Care Services Limited’s market cap?
Yatharth Hospital and Trauma Care Services Limited’s market cap is ₹83.39B.
When is Yatharth Hospital and Trauma Care Services Limited’s upcoming earnings report date?
Yatharth Hospital and Trauma Care Services Limited’s upcoming earnings report date is Aug 19, 2026 which is in 44 days.
How were Yatharth Hospital and Trauma Care Services Limited’s earnings last quarter?
Yatharth Hospital and Trauma Care Services Limited released its earnings results on May 25, 2026. The company reported ₹4.95 earnings per share for the quarter, beating the consensus estimate of N/A by ₹4.95.
Is Yatharth Hospital and Trauma Care Services Limited overvalued?
According to Wall Street analysts Yatharth Hospital and Trauma Care Services Limited’s price is currently Overvalued.
Does Yatharth Hospital and Trauma Care Services Limited pay dividends?
Yatharth Hospital and Trauma Care Services Limited does not currently pay dividends.
What is Yatharth Hospital and Trauma Care Services Limited’s EPS estimate?
Yatharth Hospital and Trauma Care Services Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Yatharth Hospital and Trauma Care Services Limited have?
Yatharth Hospital and Trauma Care Services Limited has 96,354,355 shares outstanding.
What happened to Yatharth Hospital and Trauma Care Services Limited’s price movement after its last earnings report?
Yatharth Hospital and Trauma Care Services Limited reported an EPS of ₹4.95 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -4.966%.
Which hedge fund is a major shareholder of Yatharth Hospital and Trauma Care Services Limited?
Currently, no hedge funds are holding shares in IN:YATHARTH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Yatharth Hospital and Trauma Care Services Limited
Established in 2008 and headquartered in Noida, India, Yatharth Hospital & Trauma Care Services Limited operates and manages super-specialty medical facilities across Delhi and Madhya Pradesh. These hospitals offer an extensive range of healthcare services. Core specializations include women's health (gynecology), digestive medicine (gastroenterology), respiratory conditions (pulmonology), pediatrics, kidney and urinary tract care (nephrology and urology), cardiology, orthopedics, spine and rheumatology, and neurosciences. Additionally, the company provides general medicine, surgery, ENT, physiotherapy, rehabilitation, interventional spine and pain medicine, nutrition, pathology, laboratory diagnostics, dentistry, ophthalmology, dermatology, anesthesiology, radiology, and psychology and psychiatry.
Yatharth Hospital and Trauma Care Services Limited (YATHARTH) Earnings & Revenues
Technical Analysis
Apollo Hospitals Enterprise Limited
―
Artemis Medicare Services Ltd.
―
Fortis Healthcare Ltd.
―
Max Healthcare Institute Ltd
―
Narayana Hrudayalaya Ltd.
―